Photoallergic skin reaction to ribavirin

American Journal of Gastroenterology

Volumn 94, Issue 6, 1999, Pages 1686-1688

  Stryjek Kaminska, Danuta ^a   Ochsendorf, Falk ^a   Röder, Claudia ^a   Wolter, Manfred ^a   Zeuzem, Stefan ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; PHOTOSENSITIZING AGENT; RIBAVIRIN;

ABSORPTION SPECTROSCOPY; AGED; ARTICLE; CASE REPORT; ECZEMA; FEMALE; HEPATITIS C; HUMAN; PHOTOALLERGY; PRIORITY JOURNAL; SKIN MANIFESTATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; URTICARIA;

AGED; ANTIVIRAL AGENTS; DERMATITIS, PHOTOALLERGIC; FEMALE; HEPATITIS C, CHRONIC; HUMANS; RIBAVIRIN; SKIN; ULTRAVIOLET RAYS;

EID: 0033046660     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01164.x     Document Type: Article

References (14)

1. Seeff L.B. Natural history of hepatitis C. Hepatology. 26:(suppl 1):1997;21S-28S.
2. Poynard T., Leroy V., Cohard M., et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C Effects of dose and duration . Hepatology. 24:1996;778-779.
3. Di Bisceglie A.M., Conjeevaram H.S., Fried M.W., et al. Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 123:1995;897-903.
4. Dusheiko G., Main J., Thomas H., et al. Ribavirin treatment for patients with chronic hepatitis C Results of a placebo-controlled study . J Hepatol. 25:1996;591-598.
5. Bodenheimer H.C., Lindsay K.L., Davis G.L., et al. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C A multicenter trial . Hepatology. 26:1997;473-477.
6. Brillanti S., Garson J., Foli M., et al. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology. 107:1994;812-817.
7. Lai M.Y., Kao J.H., Yang P.M., et al. Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C. Gastroenterology. 111:1996;1307-1312.
8. Reichard O., Norkrans G., Frydén A., et al. Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C. Lancet. 351:1998;83-87.
9. Davis G.L., Esteban-Mur R., Rustgi V., et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med. 339:1998;1493-1499.
10. Schalm S., Hansen B., Chemello L., et al. Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C A meta-analysis of individual patient data from European centers . J Hepatol. 26:1997;961-966.
11. de Ledinghen V., Brudieux E., Beylot-Barry M., et al. Severe local cutaneous necrosis during treatment with interferon-alpha and ribavirin for chronic viral hepatitis C. Gastroenterol Clin Biol. 21:1997;523-524. (letter).
12. Allen J.E. Drug-induced photosensitivity. Clin Pharm. 12:1994;580-587.
13. Gonzalez E., Gonzalez S. Drug photosensitivity, idiopathic photodermatosis, and sunscreens. J Am Acad Dermatol. 35:1996;871-885.
14. Gould J.W., Mercurio M.G., Elmets C.A. Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol. 33:1995;551-573.